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Amino acids injure mesangial cells by advanced glycation end
products, oxidative stress, and protein kinase C.
Background. In diabetes, high intake of dietary protein ex-
acerbates responses associated with kidney damage. Increased
levels of amino acids could injure cells by providing free amino
groups for glycation reactions leading to advanced glycation
end products (AGEs).
Methods. Rat mesangial cells were cultured with increased
amino acids designed to resemble protein feeding, high glucose
(30.5 mmol/L), and, the combination, amino acids/high glucose.
AGEs, reactive oxygen species (ROS), protein kinase C (PKC)
activity and production, and mitogen-activated protein (MAP)
kinase-extracellular signal regulated kinase (ERK) 1,2 activity
were measured. Inhibitors were used to determine roles of these
processes in fibrosis and/or AGE formation.
Results. AGE immunostaining increased when cells were cul-
tured in amino acids and was comparable to that observed
with high glucose. In amino acids/high glucose, AGE im-
munostaining appeared even greater. Amino acids, high glu-
cose, and amino acids/high glucose induced ROS production.
Aminoguanidine and vitamin E prevented AGE accumulation
and induction of protein and mRNA for fibrosis markers [trans-
forming growth factor-b1 (TGF-b1), fibronectin, and collagen
IV]. PKC and ERK 1,2 activity increased with amino acids,
high glucose, and amino acids/high glucose. PKC-b inhibition
prevented ERK 1,2 activation and fibrosis induction. ERK 1,2
inhibition also blocked the fibrosis response.
Conclusion. A profibrotic injury response occurred in mesan-
gial cells exposed to amino acids, with or without high glucose,
by formation of AGE, oxidative stress, and activation of the
PKC-b and MAP kinase-ERK 1,2 signal pathway. These obser-
vations provide new insight into cellular mechanisms of kidney
damage produced by excess dietary protein, particularly in di-
abetes.
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Diabetes is the leading cause of chronic kidney disease
and end-stage renal disease in the developed world [1, 2].
Nutritional strategies are particularly challenging due to
the complexity of controlling glycemia and other consid-
erations, including kidney disease risk. The diabetic kid-
ney has enhanced sensitivity to effects of dietary protein.
In population-based studies, higher intake of dietary pro-
tein is associated with increased risk of kidney damage in
people with diabetes and hypertension [3]. Conversely,
in meta-analyses of clinical trials, protective effects of di-
etary protein restriction are more apparent for diabetic
nephropathy than for other kidney diseases [4, 5]. Cur-
rently, the effects of dietary protein on the kidney are
especially germane due to the popularity of high pro-
tein diets for weight loss and/or control of hyperglycemia
[6–9]. In experimental models, high protein diets cause
glomerular hyperfiltration and hypertension, and kidney
damage, even more so in diabetic than in nondiabetic rats
[10, 11]. Similarly, in human studies, patients with type 1
or type 2 diabetes have an augmented glomerular hy-
perfiltration response to amino acid infusion that can be
corrected by strict glycemic control [12–14]. The mech-
anisms are unknown for the renal interactions between
hyperglycemia and increased dietary protein or amino
acids.
In order to better understand the unique sensitivity
of the diabetic kidney to dietary protein, we have re-
cently studied cellular mechanisms of glomerular injury
induced by amino acids, with or without high glucose.
The mesangial cell is a key cell involved in glomerular
hemodynamics, as well as the fibrotic and proliferative
mesangial expansion typical of diabetes. In mesangial cell
culture, an amino acid mixture, similar to the profile ob-
served in the circulation after a protein meal, induced a
number of responses associated with injury: production
and activation of transforming growth factor-b (TGF-b),
increased matrix proteins, cellular proliferation, in-
creased expression of the angiotensin type 1 receptor,
and reduced nitric oxide [15, 16]. Most of these re-
sponses were remarkably similar to those observed when
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mesangial cells were cultured in high glucose [15]. In
addition, when mesangial cells were cultured with both
high levels of amino acids and glucose, cellular prolifer-
ation was further enhanced [15]. Therefore, mechanisms
leading to glucose- and amino acid–mediated cellular re-
sponses may be shared.
Advanced glycation end products (AGEs) are well-
recognized mediators of diabetic vascular complications.
They are formed by nonenzymatic glycation of free amino
groups, followed by a complex series of sequential glyca-
tion and oxidation reactions. Previous research has fo-
cused on hyperglycemia as the main causal factor. AGE
formation occurs intracellularly and extracellularly, cul-
minating in oxidative stress and tissue injury [17, 18].
Reciprocally, oxidative stress is known to induce AGE
[19]. Protein kinase C (PKC) and mitogen-activated pro-
tein (MAP) kinase-extracellular signal regulated kinases
(ERK) 1,2 can be activated by oxidative stress and signal
profibrotic responses in kidney cells [19–24]. We hypoth-
esize that an excess of amino acids, with or without hyper-
glycemia, can enhance formation of AGE by increasing
availability of free amino groups. We also propose that
amino acid-induced AGE formation leads to oxidative
stress and activates PKC and MAP kinase-ERK 1,2 to
induce fibrosis. The aims of this study were to evaluate
effects of increased amino acids, with or without high glu-
cose, on formation of AGE and reactive oxygen species
(ROS), activity and production of PKC, and activation of
ERK 1,2 using a mesangial cell culture system. Inhibitors
of these processes were used to establish their causal roles
in fibrosis and/or AGE formation in this system.
METHODS
Mesangial cell isolation and culture
Mesangial cells were recovered from glomeruli,
isolated by sieving the cortex of kidneys excised
from 6-month-old female Sprague-Dawley rats (gift
from Donald Lightfoot, Ph.D.). Cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco
Life Technologies, Gaithersburg, MD, USA), supple-
mented with penicillin-streptomycin (100 U/mL) and
10% heat-inactivated fetal bovine serum (FBS) (Atlas
Biologicals, Fort Collins, CO, USA) in 5% carbon diox-
ide and a humidified atmosphere at 37◦C. They were pas-
saged at confluence using 0.025% trypsin (Gibco Life
Technologies) in phosphate-buffered saline (PBS) and
0.2 g/L ethylenediaminetetraacetic acid (EDTA). Mesan-
gial cells (passages 4 to 22) were seeded at 10,000 cells/cm2
into culture dishes (Nunclon, Cambridge, MA, USA):
100 mm size for mRNA analyses and PKC activity as-
say, and 60 mm size for proteins and microscopy (with
coverslips). At cellular confluence, media was changed
to serum-free DMEM for 48 hours prior to experiments.
Serum-free media was used to make cells quiescent. Oth-
Table 1. Amino acid and glucose concentrations for experimental
groups in mesangial cell culture
High Amino Amino acids/
Control glucose acids high glucose
mmol/L mmol/L mmol/L mmol/L
Glucose 5.5 30.5 5.5 30.5
L-Alanine 0 0 3.10 3.10
L-Arginine 0.40 0.40 2.48 2.48
L-Cystine 0.32 0.32 0.32 0.32
L-Glutamine 4.00 4.00 4.00 4.00
L-Glycine 0.40 0.40 2.23 2.23
L-Histidine 0.20 0.20 0.61 0.61
L-Isoleucine 0.80 0.80 1.41 1.41
L-Leucine 0.80 0.80 1.54 1.54
L-Lysine 0.80 0.80 1.22 1.22
L-Methionine 0.20 0.20 0.56 0.56
L-Phenylalanine 0.40 0.40 0.86 0.86
L-Proline 0 0 0.79 0.79
L-Serine 0.40 0.40 1.04 1.04
L-Threonine 0.80 0.80 1.27 1.27
L-Tryptophan 0.08 0.08 0.20 0.20
L-Tyrosine 0.42 0.42 0.45 0.45
L-Valine 0.80 0.80 1.45 1.45
erwise, cell culture procedures were not altered during
exposure to the experimental conditions.
Main experimental conditions
Mesangial cells were exposed to the following con-
ditions for 48 hours (Table 1): (1) control, serum-free
DMEM (glucose 5.5 mmol/L); (2) amino acids, increased
amino acids, serum-free DMEM (glucose 5.5 mmol/L)
supplemented with 10% Travasol mixed amino acid so-
lution (Baxter, Deerfield, IL, USA) and L-arginine; (3)
high glucose, serum-free DMEM (glucose 5.5 mmol/L)
supplemented with glucose (25 mmol/L) to achieve a fi-
nal concentration of 30.5 mmol/L; and (4) combination of
amino acids and high glucose. Amino acids were designed
to resemble the distribution of amino acids and relative
concentration changes produced in the circulation after
a protein meal [15, 16, 25].
Studies of AGE formation and inhibition
In response to the main experimental conditions, the
appearance of carboxymethyllysine (CML), a prominent
AGE, was evaluated in mesangial cells. CML was im-
aged by immunostaining and scanning laser confocal mi-
croscopy. The main experimental conditions were also
performed with and without addition of aminoguani-
dine (0.5 mmol/L), an inhibitor of AGE formation.
Aminoguanidine was added at the onset of the experi-
ments and continued throughout the 48-hour experimen-
tal period. Protein and mRNA for the fibrosis markers,
TGF-b1, fibronectin, and collagen IV, were measured in
the conditioned media and/or cell lysates. The effect of
aminoguanidine treatment on mesangial cell CML was
also evaluated.
Tuttle et al: Amino acids injure mesangial cells 955
Table 2. Reverse transcription-polymerase chain reaction (RT-PCR) primers for cDNA probe synthesis
Gene Genbank accession number(s) Primers cDNA size bp
Fibronectin X15906 Forward 5′-CTGGGCGAAGGCAATGGGCGTATC-3′ 727
Reverse 5′-CAAACTTCTGATCGGCATCGTAGTTC-3′
TGF-b1 X52498/RNTGFb1 Forward 5′-AATACGTCAGACATTCGGGAAG-3′ 498
Reverse 5′-GTCAATGTACAGCTGCCGTAC-3′
Collagen a1(IV) AA924749 Reverse 5′-GGAGTATTTTCAGGGTTTCG-3′ 411
Reverse 5′-TGGCAACTTCTCTTTCAACG-3′
PKC-b X04440 Forward 5′-CGAGACACCTCCAACTTCGAC-3′ 591
Reverse 5′-GACAAGAGTTCACAGTAACTGC-3′
GAPDH M17701/RGAPDH Forward 5′-AATGCATCCTGCACCACCAA-3′ 519
Reverse 5′-GCTGTAGCCATATTCATTGTC-3′
Abbreviations are: TGF-b1, transforming growth factor-b1; PKC-b , protein kinase C b ; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
Studies of oxidative stress and antioxidant treatment
As an indicator of oxidative stress, intracellular
ROS were evaluated by a fluorescent microscopy tech-
nique with the dye, dichlorodihydro-fluorescein diacetate
(DCHF-DA), under the main experimental conditions.
Treatment with vitamin E, an antioxidant, was used to
determine effects on markers of fibrosis. Its analogue, vi-
tamin E succinate, was administered to enhance cellular
transport, which facilitates the release of a-tocopherol by
membrane-bound esterases [26]. Cells were pre-loaded
with vitamin E succinate (25 lmol/L) for 48 hours prior to
the experiments to allow time for intracellular transport
and release of a-tocopherol [26]. Protein and mRNA for
the fibrosis markers, TGF-b1, fibronectin, and collagen
IV, were measured in the conditioned media and/or cell
lysates. The effect of vitamin E succinate on mesangial
cell CML was also evaluated.
Studies of PKC activity, production, and inhibition
In response to the main experimental conditions, active
and total PKC were measured by kinase phosphorylation
activity, which reflects the sum of various isoforms. Lev-
els of protein and mRNA for the b isoforms 1 and 2 were
of particular interest because PKC-b is a key signaling
mediator in diabetic vascular complications [27–29]. In
order to assess the relative importance of the b isoforms,
a general inhibitor, calphostin C (100 nmol/L), and a b
isoform inhibitor, LY-379196 (100 nmol/L), were used.
These inhibitors were added at the onset of the experi-
mental conditions and continued throughout this 48-hour
period. For the fibrosis markers (TGF-b1, fibronectin,
and collagen IV), protein was measured in the condi-
tioned media and/or cell lysates. The effects of calphostin
C and LY-379196 on ERK 1,2 activation under the main
experimental conditions were also assessed (see below).
Studies of ERK 1,2 activation and inhibition
The effect of the main experimental conditions on ERK
1,2 activation was evaluated by measuring the propor-
tion of the phosphorylated form relative to total ERK
1,2 by Western blot in cell lysates. PD98059, an inhibitor
of ERK 1,2 activation, was added to the experimental
conditions in order to establish that ERK 1,2 is a signal
for expression of fibrosis markers. PD98059 (25 lmol/L)
was added at the onset of the experimental conditions
and continued throughout this 48-hour period. Proteins
for TGF-b1, fibronectin, and collagen IV were measured
in the conditioned media and/or cell lysates.
Analytic techniques
RNA purification and Northern blots. RNA was puri-
fied from mesangial cells using Tri Reagent (Molecular
Research Center, Cincinnati, OH, USA) and quanti-
fied by ultraviolet spectrophotometry (Beckman DU
640) (Beckman Coulter, Fullerton, CA, USA) [15].
For Northern blots, RNA (5 lg) was denatured, sepa-
rated by formaldehyde agarose gel electrophoresis, trans-
ferred to charged nylon membranes (Schleicher and
Schuell, Keene, NH, USA), and baked at 80◦C. Reverse
transcriptase-polymerase chain reaction (RT-PCR) was
used to prepare cDNA probes for Northern blot hy-
bridization (Table 2). Total rat kidney RNA (2.5 lg)
was reverse transcribed after annealing with random
hexamers (First-Strand cDNA Synthesis Kit) (Madison,
WI, USA). PCR was performed using 1 lL of each RT
reaction mixture in a reaction of 100 lL. Each reac-
tion contained 200 pmol/L of primer pairs (Integrated
DNA Technologies, Coraville, IA, USA) and MgCl2 (3
mmol/L) with PCR reagents (Promega, Madison, WI,
USA). PCR was initiated by denaturation at 95◦C for 4
minutes, followed by 30 cycles at 60◦C, 73◦C, and 95◦C for
1 minute each. Amplified cDNA was gel purified (Qiagen,
Valencia, CA, USA). The cDNA probes were 32P-labeled
using 32P-deoxycytidimine triphosphate (dCTP) with the
DECAprime II DNA labeling kit (Ambion, Austin, TX,
USA). Blots were hybridized in 0.25 mol/L Na2HPO4,
pH 7.2, 0.25 mol/L NaCl, 7% sodium dodecyl sulfate
(SDS), and 1 mmol/L EDTA, with 32P-labeled cDNA at
2 × 106 cpm/mL for 24 hours at 68◦C. Blots were then
washed at 60◦C with 0.1 × standard sodium citrate (SSC)
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Fig. 1. Carboxymethyllysine (CML) immunostaining. Mesangial cells were exposed to control, amino acids, high glucose, and amino acids/high
glucose conditions for 48 hours. The cells were then fixed and processed for scanning laser confocal microscopy. A mouse monoclonal antibody
to CML and fluorescein-conjugated goat secondary antibody (green) were used to identify advanced glycation end products (AGEs) in the cells.
Nuclei were stained with propidium iodide (red). These photomicrographs show representative fields of confluent mesangial cells. Main experimental
conditions are shown with aminoguanidine (A to D), no addition (E to H), and vitamin E (I to L). Abbreviations are: AA, amino acids; HG, high
glucose; AA/HG, amino acids/high glucose.
(15 mmol/L NaCl and 1.5 mmol/L sodium citrate) con-
taining 0.1% SDS. Northern blots were quantified from
digital images obtained with the Cyclone Storage Phos-
phor System and Optiquant Image Analysis software
(Packard Instruments, Meriden, CT, USA). Quantities
of mRNA were expressed as the ratio to glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) mRNA.
Protein assays. Cell culture conditioned media was
collected, and 2 lg/mL each of protease inhibitors,
pepstatin, leupeptin, antipain, and aprotinin (Sigma
Chemical Co., St. Louis, MO, USA) were added to ex-
perimental samples used for enzyme-linked immunosor-
bent assay (ELISA). Samples were assayed immediately
or stored frozen at −70◦C until tested. A competi-
tion ELISA technique was used to measure fibronectin
[15]. TGF-b1 was measured by ELISA with the Du-
oset Kit (R&D Systems, Minneapolis, MN, USA) [15].
Total protein was determined with the Bio-Rad Pro-
tein Assay Kit (Bio-Rad Laboratories, Hercules, CA,
USA). Absorbances were detected with a BioTek FL-600
plate reader (BioTek Instruments, Winooski, VT, USA).
ELISA measurements were calculated as ratios to total
protein in media (pg/lg or ng/lg).
Western blot techniques were used to measure col-
lagen IV, PKC-b1 and 2, and total and phosphorylated
ERK 1,2 in cell lysates. Cells were lysed in RIPA buffer
[50 mmol/L Tris, pH 8.0, 150 mmol/L NaCl, 0.5 mmol/L
EDTA, 1 mmol/Ldithiothreitol (DTT), 1% NP-40, 0.5%
sodium deoxycholate, and 0.1% SDS]. Samples were
separated through denaturing SDS-polyacrylamide gel
electrophoresis (PAGE) (4% to 20% gradient) and
transferred to a nitrocellulose membrane, blocked in
Tris-buffered saline containing 0.05% Tween-20, and
5% bovine serum albumin (BSA). The samples were
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Fig. 2. Protein measurements for mesangial cells cultured under the main experimental conditions with no addition and with aminoguanidine. (A)
Transforming growth factor-b1 (TGF-b1) (pg/lg). (B) Fibronectin (ng/lg). (C) Collagen IV (density units/lg).∗P < 0.01 versus control (N = 9–14).
Abbreviations are: C, control; AA, amino acids; HG, high glucose; AA/HG, amino acids/high glucose.
then incubated with antibodies that react with rat pro-
teins: collagen IV (goat) (Southern Biotechnology Asso-
ciates, Birmingham, AL, USA), PKC-b1 and 2 (rabbit)
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA),
ERK 1,2 and dual phosphorylated (Thr202/Thr204) ERK
1,2 (rabbit) (Cell Signaling Technology, Beverly, MA,
USA). These antibodies to rat proteins were detected
with horseradish peroxidase-conjugated secondary anti-
bodies (mouse antigoat and donkey antirabbit) (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA),
followed by chemiluminescent detection using Super Sig-
nal West substrate (Pierce, Rockford, IL, USA). Digi-
tized images were generated and analyzed using a Chemi-
doc XRS system and Quantity One 1D software (Bio-Rad
Laboratories). The DC Protein Assay Kit (BioRad Lab-
oratories) was used to measure total protein in the cell
lysates. Western blot measurements were calculated as
ratios to total protein (density units/lg).
CML immunostaining and scanning laser confocal mi-
croscopy. Mesangial cells were grown on 13 mm round
Thermanox coverslips (Nunc, Electron Microscopy Sci-
ences, Ft. Washington, PA, USA), fixed for 5 minutes with
100% methanol, and air-dried before storing at −20◦C.
Cells were rehydrated and incubated overnight with a
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Fig. 3. Quantitative measures of mRNA in mesangial cells cultured under the main experimental conditions with no addition and with aminoguani-
dine. (A) Transforming growth factor-b1 (TGF-b1). (B) Fibronectin. (C) Collagen a1(IV). Data are displayed as ratios to glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA. (D) Representative Northern blots. ∗P < 0.05 versus control (N = 11–13). Abbreviations are: C,
control; AA, amino acids; HG, high glucose; AA/HG, amino acids/high glucose.
mouse monoclonal anti-CML antibody (Research Diag-
nostics, Flanders, NJ, USA). A secondary goat antibody
conjugated with fluorescein was used to identify the anti-
CML antibody. Cells were washed and mounted on cov-
erslips using Vectashield mounting medium (Vector Lab-
oratories, Burlingame, CA, USA) containing propidium
iodide to stain cell nuclei for visualization. Cellular fluo-
rescence was imaged with a Bio-Rad 1024 scanning laser
confocal microscope (Bio-Rad Laboratories).
ROS detection by fluorescence microscopy. ROS gen-
eration (predominantly hydrogen peroxide) was assessed
using the fluorescent dye, DCHF-DA (Molecular Probes,
Eugene, OR, USA). Mesangial cells were grown on
13 mm round Thermanox coverslips (Nunc, Electron Mi-
croscopy Sciences). After 4 and 48 hours of growth in
the main experimental conditions, cells were washed with
DMEM and incubated with DCHF-DA (10 lmol/L) for
30 minutes. Subsequently, cells were washed again with
DMEM, and the coverslips were mounted on a glass slide
using a mixture of PBS and Vectashield (Vector Labora-
tories). A positive control for ROS was made by culture
of mesangial cells in control conditions followed by expo-
sure to hydrogen peroxide (100 lmol/L) for 15 minutes
prior to addition of DCHF-DA. To demonstrate that hy-
drogen peroxide was the source of the fluorescence, un-
der each condition (positive control and experimental)
catalase (80 U/mL) was administered 30 minutes prior
to addition of DCHF-DA to degrade hydrogen peroxide.
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Fig. 4. Reactive oxygen species (ROS) detection by fluorescence microscopy. Mesangial cells were exposed to the main experimental conditions for
48 hours. The fluorescent dye, dichlorodihydro-fluorescein diacetate (DCHF-DA), was used to identify ROS in representative fields of mesangial
cells cultured under control (A), amino acids (AA) (B), high glucose (HG) (C), and amino acids/high glucose (AA/HG) (D) conditions. For a
positive control, mesangial cells were exposed to hydrogen peroxide (100 lmol/L) prior to addition of DCHF-DA (E).
Mesangial cells were viewed with an Axioplan II fluores-
cence microscope (Zeiss, Gottingen, Germany) equipped
with a triple-bandpass filter. Digital images were captured
and stored using Isis software version 3.4.0 (Metasystems,
Altlussheim, Germany).
PKC activity assay. Cells were washed with 7 mL
of ice-cold PBS and scraped into 0.5 mL of ice-
cold extraction buffer (25 mmol/L Tris-HCl, pH 7.4,
0.5 mmol/L EDTA, 0.5 mmol/L EGTA, 0.05% Triton X-
100, 10 mmol/L b-mercaptoethanol, 1 lg/mL leupeptin,
1 lg/mL aprotinin, and 100 mmol/L 4,2-aminoethyl-
benzenesulfonylfluoride HCl). The mixture was soni-
cated with two 5-second bursts using a probe sonicator
(Sonic Dismembranator 60) (Fisher Scientific, Pitts-
burgh, PA, USA). Cell lysates were centrifuged for
5 minutes at 14,000 × g to remove nuclei and debris.
Supernatants were recovered and assayed for kinase
phosphorylation activity by measuring incorporation of
[c-32P]-adenosine monophosphate (ATP) into the sub-
strate, neurogranin, using the SignaTECT PKC Assay
System (Promega, Madison, WI, USA). To derive a
measure of total PKC, activators (phosphatidylserine,
320 lg/mL, and diacylglycerol, 32 lg/mL) were added to
cell lysates to convert the inactive form to active PKC.
The DC Protein Assay Kit (Bio-Rad Laboratories) was
used to measure total protein in the cell lysates. Re-
sults were expressed as pmol ATP/minute/lg of total
protein.
Statistics
Data were expressed as mean ± SE. One-way re-
peated measures analysis of variance (ANOVA) was used
to evaluate outcome measurements in response to the
main experimental conditions. Two-way repeated mea-
sures ANOVA was used to assess differences in outcome
measurements between groups when the experimental
conditions were performed with and without inhibitors
of the various processes. Specific tests were conducted
using a priori contrasts. Statistical significance was set at
two-tailed probabilities less than 5% (P < 0.05). SPSS
version 10 (SPSS, Chicago, IL, USA) was the software
used for the statistical analyses.
RESULTS
AGE formation and inhibition
In mesangial cells cultured in the amino acid condi-
tion, immunostaining for CML clearly increased com-
pared to control (Fig. 1E and F). This increase in cellular
CML was similar to that observed in the high glucose
condition (Fig. 1G). In consecutive experiments, inten-
sity of CML immunostaining appeared greater in amino
acid/high glucose than that in either condition alone
(Fig. 1H). Treatment with an inhibitor of AGE forma-
tion, aminoguanidine, prevented the increase in cellular
CML under each of these conditions (Fig. 1A to D). These
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Fig. 5. Protein measurements for mesangial cells cultured under the main experimental conditions with no addition and with vitamin E. (A)
Transforming growth factor-b1 (TGF-b1) (pg/lg). (B) Fibronectin (ng/lg). (C) Collagen IV (density units/lg). ∗P < 0.01 versus control (N = 9–14).
Abbreviations are: C, control; AA, amino acids; HG, high glucose; AA/HG, amino acids/high glucose.
images (Fig. 1) are representative of those obtained in
the series of experiments (N = 7). Protein and mRNA
for TGF-b1, fibronectin, and collagen IV increased sig-
nificantly in response to amino acids, high glucose, and
amino acids/high glucose (Figs. 2 and 3). Aminoguanidine
treatment reduced both protein and mRNA for these fi-
brosis markers to control levels.
Oxidative stress and antioxidant treatment
The amino acid condition induced mesangial cell pro-
duction of ROS (Fig. 4A and B). Similarly, high glucose
and amino acids/high glucose induced ROS produc-
tion (Fig. 4C and D). ROS were observed in mesangial
cells cultured with amino acids, high glucose, and amino
acids/high glucose at both the 4-hour (data not shown)
and 48-hour time points. Treatment of mesangial cells
cultured under the main experimental conditions with
vitamin E succinate prevented increased expression of
TGF-b1, fibronectin, and collagen IV at both the pro-
tein and mRNA levels (Figs. 5 and 6). The increases in
mesangial cell CML induced by amino acids, high glu-
cose, and amino acids/high glucose were also inhibited
by treatment with vitamin E succinate (Fig. 1I to L).
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Cell signaling via PKC and MAP
kinase-ERK 1,2 pathway
The active portion of PKC increased in mesan-
gial cells cultured with amino acids, high glucose, and
amino acids/high glucose conditions compared to control
(Fig. 7A). However, total PKC did not increase (Fig. 7B).
No increase in protein for the PKC-b isoforms 1 and 2
was observed in mesangial cells exposed to the main ex-
perimental conditions (Fig. 8A and B). Similarly, mRNA
expression for PKC-b (probe detects isoforms 1 and 2)
was not altered by these conditions (Fig. 8C and D). Two
bands (10 kb and 3.6 kb) representing PKC-b mRNA
were detected; this pattern is believed to reflect post-
transcriptional processing [30, 31]. Inhibition of PKC-
b with LY-379196 blocked the profibrotic response of
mesangial cells to amino acids, high glucose, and amino
acids/high glucose in a manner similar to that observed
with the general PKC inhibitor, calphostin C (Fig. 9).
Amino acids, high glucose, and amino acids/high glucose
increased phosphorylation of ERK 1,2, an index of its
activation, in mesangial cells (Fig. 10). Treatment with ei-
ther LY-379196 or calphostin C inhibited ERK phospho-
rylation in response to the main experimental conditions
(Fig. 10). The inhibitor of ERK 1,2, PD098059, prevented
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Fig. 7. Active (A) and total (B) protein kinase C (PKC) as determined
by kinase phosphorylation activity in mesangial cells cultured under the
main experimental conditions. ∗P < 0.01 versus control (N = 8). Abbre-
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amino acids/high glucose.
increases in protein for TGF-b1, fibronectin, and colla-
gen IV in mesangial cells cultured with amino acids, high
glucose, and amino acids/high glucose (Fig. 11).
DISCUSSION
When mesangial cells were exposed to elevated lev-
els of amino acids designed to resemble protein feeding,
they produced AGEs and ROS in a manner compara-
ble to responses observed when cells were cultured in a
glucose concentration typical of hyperglycemia. The im-
munofluorescent images suggested that even more AGEs
could be formed when levels of both amino acids and
glucose were increased. An inhibitor of AGE formation,
aminoguanidine, prevented induction of CML and indi-
cators of fibrosis (TGF-b1, fibronectin, and collagen IV)
when mesangial cells were cultured with amino acids,
high glucose, and amino acids/high glucose. Similarly,
these responses were prevented by an antioxidant, vi-
tamin E succinate. The cell signaling pathway of PKC
and MAP kinase-ERK 1,2 was activated by amino acids,
with or without concomitant high glucose. As determined
by inhibition studies, PKC-b was largely responsible for
ERK 1,2 phosphorylation and the profibrotic response of
mesangial cells cultured under these conditions. Since no
increase in total PKC-b isoform mRNA or proteins 1 and
2 was observed, the increase in activity appears to be due
to activation, rather than production, in this system. The
role of ERK 1,2 in the cell signaling sequence was con-
firmed by inhibition studies demonstrating prevention of
fibrosis.
These data support a unifying hypothesis of AGE for-
mation and oxidative stress to potentially explain in-
creased renal sensitivity to dietary protein in diabetes,
as well as links between amino acids and mesangial cell
injury in nondiabetic disease processes (Fig. 12). To our
knowledge, this is the first demonstration that an amino
acid mixture, typical of the plasma profile produced by
protein feeding, induces formation of AGEs and ROS
in mesangial cells. The accumulation of AGEs and the
profibrotic response to amino acids were prevented by
treatment with an inhibitor of AGE formation. Since in-
hibition appeared to be complete in both aspects, these
data indicate that AGE formation is a primary cause
of fibrotic injury induced by amino acids in mesan-
gial cells. Therefore, free amino acids, as well as amino
groups on long-lived structural proteins, may participate
in glycation reactions leading to cell injury. Although the
immunofluorescence pattern suggested greater CML ac-
cumulation in response to the combination condition of
amino acids/high glucose, confirmation of this impres-
sion will require quantitative measurements. These data
have implications for understanding effects of high pro-
tein diets on diabetic, as well as nondiabetic, kidney dis-
eases. Recently, in the Nurses’ Health Study, women with
mild renal insufficiency (glomerular filtration rate 55 to
80 mL/minute) were reported to have a 3.5-fold increased
risk of losing renal function if dietary protein intake was
in the highest (90 g/day) versus lowest quintile (60 g/day)
[32]. Similarly, high protein diets have long been known
to accelerate kidney disease in nondiabetic animal mod-
els such as aging and renal ablation [11, 33]. Glomeru-
lar hyperfiltration and hypertension are well-established
mechanisms of injury produced by high protein diets
[33]. However, accumulating clinical and experimental
evidence indicates that nonhemodynamic mechanisms
may also contribute to this type of kidney damage [34–
37]. Our in vitro system, which was free of influences
from hemodynamics or disturbances in other metabo-
lites and hormones, demonstrated that AGE formation
is a strong candidate mechanism for nonhemodynamic
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injury induced by high amino acid levels typical of pro-
tein feeding.
A number of specific transporters move glucose and
amino acids into cells [38]. Based on the available data,
we cannot determine if amino acids were glycated intra-
cellularly or extracellularly and then incorporated into
cellular proteins. However, even if incorporation did
not occur, reactions with amino acids produce oxidative
stress, which have a number of detrimental consequences,
including perpetuation of AGE formation on preexisting
proteins [39]. In mesangial cells exposed to amino acids,
high glucose, and amino acids/high glucose, CML was re-
duced by an antioxidant, vitamin E, suggesting that oxida-
tive stress facilitates AGE formation in this model. Thus,
interactions between AGE and ROS can be viewed as
a reciprocal, positive feedback system. Oxidative stress
also appears to be a critical component of the mesangial
cell injury response to amino acids because vitamin E
treatment completely blocked induction of fibrosis.
In order to explore signaling mechanisms responsible
for the profibrotic response induced by amino acids, the
PKC and MAP kinase-ERK 1,2 pathway was evaluated.
This pathway is known to signal cellular injury related
to AGE and glucose-induced oxidative stress [20, 21, 23,
24]. PKC-b can be activated by AGE and oxidative stress
in mesangial cells, even without exposure to high glucose
levels [20]. In response to amino acids with or without
high glucose, PKC activity increased. Studies with in-
hibitors of AGE formation and oxidative stress should
be performed to confirm that these mechanisms are also
responsible for amino acid-induced PKC activation. Fur-
thermore, even though PKC activity increased, total PKC
and the mRNA and protein for the b isoforms did not in-
crease. Since inhibition of ERK 1,2 activation and of the
profibrotic response was complete with both the general
and b-specific inhibitors, PKC-b appears to account for
the increased activity in this system. In addition, inhibi-
tion of ERK 1,2 fully prevented the profibrotic response
to amino acids, high glucose, and amino acids/high glu-
cose. Therefore, ERK 1,2 also is a critical signal for this
cell injury response. PKC-b is one of at least 12 isoforms,
which is further subdivided into isoforms 1 and 2 [40].
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These b isoforms are derived from alternative splicing of
a single mRNA transcript [41]. In glomeruli and mesan-
gial cells, PKC-b1 is a predominant active form [27, 28].
Although PKC-b2 is largely confined to renal interstitial
macrophages in diabetic rats, we and others have found
small amounts of this isoform in cultured mesangial cells
[27]. The relative contributions of PKC-b1 and 2 to ERK
1,2 activation and fibrosis remain unknown because their
expression levels did not change and LY379196 inhibits
both b isoforms.
Several other lines of evidence support the hypothe-
sis that amino acids may cause cell and tissue damage
via AGE formation and oxidative stress. Anderson et al
[42] reported that neutrophils cultured with a physiologic
amino acid mixture and a normal glucose concentration
produced CML. In another study, neutrophils cultured
with an elevated level of the single amino acid glutamine
increased production of ROS and nicotinamide adenine
dinucleotide phosphate oxidase components, both indi-
cators of oxidative stress [43]. A high methionine diet ac-
tivated nuclear factor kappaB (NF-jB) and up-regulated
inducible nitric oxide synthase (iNOS) expression in kid-
neys of normal rats, suggesting a role in renal injury
[44]. Finally, patients with end-stage renal disease who
used a mixed amino acid solution for just one peritoneal
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Fig. 10. Extracellular signal-regulated kinase (ERK) 1,2 activation as
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total ERK1,2 in mesangial cells cultured under the main experimental
conditions with no addition and with LY379196 and calphostin C. (A)
Representative Western blot. (B) Quantitative measures of proteins. ∗P
< 0.01 versus control; †P < 0.05 versus control (N = 12). Abbreviations
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dialysis exchange developed endothelial dysfunction as
determined by impaired brachial artery reactivity [45].
Although these studies did not address the specific mech-
anisms of NF-jB activation or endothelial dysfunction,
such consequences are typical of AGE formation and ox-
idative stress [17, 18, 46]. Therefore, both in vitro and
in vivo, increased exposure to various individual amino
acids and combinations produces manifestations of cell
and tissue damage, which are consistent with effects of
AGE and oxidative stress. These studies also suggest that
amino acid-induced injury could be produced in sites
other than the kidney, and that the arterial circulation
may be particularly vulnerable.
This in vitro study has important limitations. First, we
do not know if specific amino acids are more reactive than
others because mesangial cells were exposed to a mixed
solution. Amino acids with more than one amino group
could be particularly reactive due to increased sites for
glycation reactions. Previously, we have shown that expo-
sure of mesangial cells to such an individual amino acid, L-
arginine, produced a profibrotic response and reduction
of nitric oxide in the conditioned media, presumably due
to oxidative quenching [15]. Second, cells were exposed
to increased amino acid levels continuously. Now that
the plausibility of amino acid–induced AGE formation
has been established, responses to pulsatile exposure,
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Fig. 12. Unifying hypothesis for fibrotic injury induced by increased
amino acids, with or without high glucose, in mesangial cells. Arrows
indicate proposed sequence of events. The large arrow represents the
potential for an enhanced effect on advanced glycation end products
formation by the combination of increased amino acids and high glu-
cose conditions. Bidirectional arrows between advanced glycation end
which more closely mimics feeding patterns, would be
informative. Third, serum-free media may have been a
stress to the cells. However, under the control condition
with serum-free media, no evidence of increased oxida-
tive stress or AGE formation was observed. Nevertheless,
experiments with the addition of serum would produce a
more physiologic condition to examine effects of amino
acids on AGE formation, oxidative stress, PKC activa-
tion, and cell injury. Fourth, the inhibitors could have
actions other than those for which they were intended.
Aminoguanidine has antioxidant properties and can in-
hibit iNOS [47]. However, in our in vitro experimental
system, iNOS mRNA has not been detected (unpublished
observations). Thus, aminoguanidine is unlikely to func-
tion as an iNOS inhibitor in this system. Vitamin E has
been reported to inhibit PKC by nonantioxidant molecu-
lar interactions [48]. Other inhibitors of AGE formation
and oxidative stress should be evaluated to confirm the
present results. Although the various kinase inhibitors
are believed to be relatively specific at the dosages used,
cross-reactivity between them cannot be completely ex-
cluded [49]. Despite these limitations, the unifying hy-
pothesis is supported by the consistency of the overall
evidence (Fig. 12). Finally, it is possible that the amino
acid solution contained preformed AGE. Since the im-
munofluorescence images of mesangial cells treated with
aminoguanidine or vitamin E showed no visible increase
in AGEs with addition of amino acids, preformed AGEs
were unlikely to have been derived from the solution be-
cause these agents work by inhibiting AGE formation.
However, even if some preformed AGEs were present
in the solution and/or media, this may be relevant to
the in vivo state. Consumption of foods with increased
amounts of AGE-modified proteins has been reported to
increase circulating AGE levels and inflammatory mark-
ers in diabetic subjects [50]. In mouse models, diets low
in AGEs prevented glomerulosclerosis despite persistent
hyperglycemia [51]. Since AGE-modified proteins would
be absorbed as glycated amino acids and peptides, these
data indicate that such protein fragments, not only AGE-
modified intact proteins, have the potential to produce
cell and tissue damage.
CONCLUSION
Mesangial cells exposed to a mixture of amino acids,
designed to resemble protein feeding, produced a profi-
brotic response as a consequence of AGE and ROS for-
mation, presumably induced by increased availability of
products and reactive oxygen species reflect their relationship as a re-
ciprocal, positive feedback system. Abbreviations are: MAP, mitogen-
activated protein; ERK 1,2, extracellular signal-regulated kinase; TGF-
b , transforming growth factor-b .
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amino groups for glycation reactions. To our knowledge,
this is the first demonstration that amino acids induce
AGE formation in mesangial cells and that they may en-
hance such an effect of glucose. PKC-b and the MAP
kinase-ERK 1,2 pathway signal the profibrotic response
to amino acids. These observations provide insight into
cellular mechanisms of renal injury induced by amino
acids and a potential explanation for the enhanced sensi-
tivity of the diabetic kidney to dietary protein.
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